5 Ways Healthcare Organizations are Using SDOH to Make a Difference

So much of our overall health is impacted by various socioeconomic factors, which don’t involve ever stepping foot into a doctor’s office, clinic or hospital. Social determinants of health—commonly referred to as SDOH—and healthcare utilization have an evidenced correlation. It’s estimated that as much as 80% of socioeconomic factors determine our health. That’s significant. As healthcare organizations—hospitals, health systems and payers—look to curb costs and operate more efficiently, there’s growing evidence pointing to the importance of understanding and addressing SDOH.

Healthcare organizations are using SDOH data in the following ways:

  1. Risk stratification
    Socioeconomic data can be used as one of a few sources to determine what level of risk a patient/member is for high utilization—low risk, moderate risk, rising risk, high risk, etc. In addition to using clinical and claims data, adding socioeconomic data provided by a third party can enhance risk scores built in-house. As a result, organizations can build comprehensive models to segment populations and better manage health outcomes.
  2. Predictive analytics
    By combining socioeconomic data with clinical and claims information, healthcare organizations have been able to identify potential high-risk groups/individuals and determine which socio-clinical interventions to deploy.
  3. Social needs referrals
    SDOH data has been a boon for social workers and care managers. Armed with the right information and tools, they’re able to make accurate referrals to community-based organizations like food banks, transportation services, temporary housing assistance, job training programs and financial aid services. SDOH data helps knock down barriers to care that often lead to bigger, more costly healthcare issues down the line. SDOH data helps solve that. For example, a produce-prescription program in Ward 8 of Washington, DC brought a diversified team together to improve health for pre-diabetic, diabetic and hypertensive individuals who faced food insecurity. The program provides a $20 per week prescription for fruits and vegetables, as well as a nutritional consult. Improvements, such as a decrease in ED visits and hospitalizations and an increase in primary care, have already been seen.
  4. Individual care interventions
    Individual-level datasets inform care managers of specific socioeconomic needs the organization can directly address. For example, without reliable public or personal transportation, patients may skip annual checkups, follow-up visits and recommended screenings. Free rides can be offered to and from the physician’s office to ensure they can make their appointment.

Aggregated data sets are being leveraged to identify which specific neighborhoods would benefit most from SDOH interventions. For example, hospitals in areas with high numbers of homelessness have provided patients facing housing instability with a safe and supportive place to heal after hospital discharge.

FinThrive Social Determinant Risk Attributes delivers individualized (evidence-based data from 90,000+ sources and matched at patient level) and aggregated (neighborhood data down to the ZIP + 4 level) socioeconomic datasets.

Learn more about how FinThrive is advancing health equity through data. See Our SDOH Story.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More